Biogen Appoints Jane Grogan as Head of Research
CAMBRIDGE, Mass., Sept. 06, 2023 -- Biogen Inc. announced the appointment of Jane Grogan, Ph.D., as Executive Vice President, Head of Research effective 2 October 2023. Dr. Grogan will be a member...
Stay updated with breaking news from Jack Cox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass., Sept. 06, 2023 -- Biogen Inc. announced the appointment of Jane Grogan, Ph.D., as Executive Vice President, Head of Research effective 2 October 2023. Dr. Grogan will be a member...
How Texas became a two-party state in spite of the GOP.
Postpartum depression (PPD) approval based on results from two Phase 3 clinical trials; in the SKYLARK Study treatment with ZURZUVAE rapidly improved symptoms of PPD at Day 15 and as early as Day 3 with sustained effect to Day 45Mental health conditions are the leading cause of maternal mortality1 with PPD among the...
SKYCLARYS® recently approved in US as the only treatment indicated for patients with Friedreich’s ataxia Proposed acquisition represents meaningful step…
Biogen to Acquire Reata Pharmaceuticals SKYCLARYS® recently approved in US as the only treatment indicated for patients with Friedreich's...